{"title":"2017年7月至2018年6月，儿科住院医师Kandou Manado教授的抗生素治疗评估图","authors":"Erfand Polii, Christi D. Mambo, J. Posangi","doi":"10.35790/EBM.6.2.2018.22175","DOIUrl":null,"url":null,"abstract":"Abstract: Bronchopneumonia is still one of the health problems worldwide due to its high mortality rate. The definitive treatment for this disease is antibiotics. However, the use of antibiotics in hospitals is 30-80% not for the right indication. This study was aimed to obtain the description of evaluation of antibiotic therapy in bronchopneumonia patients in the Pediatrics Inpatient Installation of Prof. Dr. R. D. Kandou Hospital Manado in the period of July 2017 - June 2018. This was a descriptive retrospective study with a cross-sectional design. Evaluation was done by using quantitative methods of DDD by WHO. The results of DDD/100-day evaluation using 41 samples were cefixime 141.63 DDD/100-day (48%), ampicillin 123.51 DDD /100-day (42%), cefotaxime 10.52 DDD/100-day (4%), gentamicin 8.88 DDD/ 100-day (3%), chloramphenicol 8.68 DDD/100-day (3%), and ceftriaxone 3.06 DDD/100-day (1%). Antibiotics included in 90% of the DU segment were cefixime and ampicillin. Conclusion: The most quantitative description evaluation of antibiotic therapy in bronchopneumonia patients was cefixime 141.63 DDD/100-day.Keywords: antibiotics, bronchopneumonia, DDD Abstrak: Bronkopneumonia menjadi salah satu masalah kesehatan di dunia karena angka kematiannya yang tinggi. Pengobatan definitifnya yaitu dengan pemberian antibiotik. Di berbagai rumah sakit, ditemukan 30-80% penggunaan antibiotik tidak didasarkan pada indikasi yang tepat. Penelitian ini bertujuan untuk mengetahui gambaran evaluasi terapi antibiotik pada pasien bronkopneumonia di Instalasi Rawat Inap Anak RSUP Prof. Dr. R. D. Kandou Manado periode Juli 2017 - Juni 2018. Jenis penelitian ialah deskriptif retrospektif dengan desain potong lintang. Evaluasi menggunakan metode kuantitatif DDD oleh WHO. Hasil evaluasi antibiotik DDD/100-hari dari 41 sampel yaitu cefiksim 141,63 DDD/100-hari (48%), ampicilin 123,51 DDD/100-hari (42%), cefotaksim 10,52 DDD/100-hari (4%), gentamisin 8,88 DDD/100-hari (3%), kloramfenikol 8,68 DDD/100-hari (3%), dan ceftriakson 3,06 DDD/100-hari (1%). Antibiotik yang masuk dalam segmen DU 90% yaitu cefiksim dan ampicilin. Simpulan: Secara kuantitas gambaran evaluasi terapi antibiotik terbanyak pada pasien bronkopneumonia yaitu cefiksim 141,63 DDD/100-hari.Kata kunci: antibiotik, bronkopneumonia, DDD","PeriodicalId":17693,"journal":{"name":"Jurnal e-Biomedik","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Gambaran Evaluasi Terapi Antibiotik pada Pasien Bronkopneumonia di Instalasi Rawat Inap Anak RSUP Prof. Dr. R. D. Kandou Manado Periode Juli 2017 – Juni 2018\",\"authors\":\"Erfand Polii, Christi D. Mambo, J. Posangi\",\"doi\":\"10.35790/EBM.6.2.2018.22175\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract: Bronchopneumonia is still one of the health problems worldwide due to its high mortality rate. The definitive treatment for this disease is antibiotics. However, the use of antibiotics in hospitals is 30-80% not for the right indication. This study was aimed to obtain the description of evaluation of antibiotic therapy in bronchopneumonia patients in the Pediatrics Inpatient Installation of Prof. Dr. R. D. Kandou Hospital Manado in the period of July 2017 - June 2018. This was a descriptive retrospective study with a cross-sectional design. Evaluation was done by using quantitative methods of DDD by WHO. The results of DDD/100-day evaluation using 41 samples were cefixime 141.63 DDD/100-day (48%), ampicillin 123.51 DDD /100-day (42%), cefotaxime 10.52 DDD/100-day (4%), gentamicin 8.88 DDD/ 100-day (3%), chloramphenicol 8.68 DDD/100-day (3%), and ceftriaxone 3.06 DDD/100-day (1%). Antibiotics included in 90% of the DU segment were cefixime and ampicillin. Conclusion: The most quantitative description evaluation of antibiotic therapy in bronchopneumonia patients was cefixime 141.63 DDD/100-day.Keywords: antibiotics, bronchopneumonia, DDD Abstrak: Bronkopneumonia menjadi salah satu masalah kesehatan di dunia karena angka kematiannya yang tinggi. Pengobatan definitifnya yaitu dengan pemberian antibiotik. Di berbagai rumah sakit, ditemukan 30-80% penggunaan antibiotik tidak didasarkan pada indikasi yang tepat. Penelitian ini bertujuan untuk mengetahui gambaran evaluasi terapi antibiotik pada pasien bronkopneumonia di Instalasi Rawat Inap Anak RSUP Prof. Dr. R. D. Kandou Manado periode Juli 2017 - Juni 2018. Jenis penelitian ialah deskriptif retrospektif dengan desain potong lintang. Evaluasi menggunakan metode kuantitatif DDD oleh WHO. Hasil evaluasi antibiotik DDD/100-hari dari 41 sampel yaitu cefiksim 141,63 DDD/100-hari (48%), ampicilin 123,51 DDD/100-hari (42%), cefotaksim 10,52 DDD/100-hari (4%), gentamisin 8,88 DDD/100-hari (3%), kloramfenikol 8,68 DDD/100-hari (3%), dan ceftriakson 3,06 DDD/100-hari (1%). Antibiotik yang masuk dalam segmen DU 90% yaitu cefiksim dan ampicilin. Simpulan: Secara kuantitas gambaran evaluasi terapi antibiotik terbanyak pada pasien bronkopneumonia yaitu cefiksim 141,63 DDD/100-hari.Kata kunci: antibiotik, bronkopneumonia, DDD\",\"PeriodicalId\":17693,\"journal\":{\"name\":\"Jurnal e-Biomedik\",\"volume\":\"12 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurnal e-Biomedik\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35790/EBM.6.2.2018.22175\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal e-Biomedik","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35790/EBM.6.2.2018.22175","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
摘要
摘要:支气管肺炎因其高致死率一直是全球健康问题之一。这种疾病的最终治疗方法是抗生素。然而，医院中抗生素的使用有30-80%不是为了正确的指征。本研究旨在获得2017年7月至2018年6月，Dr. Dr. Kandou Hospital Manado儿科住院部对支气管肺炎患者抗生素治疗的评价描述。这是一项横断面设计的描述性回顾性研究。采用世界卫生组织DDD定量方法进行评价。41份样品的DDD/100天评价结果为:头孢克肟141.63 DDD/100天(48%)、氨苄西林123.51 DDD/100天(42%)、头孢噻肟10.52 DDD/100天(4%)、庆大霉素8.88 DDD/100天(3%)、氯霉素8.68 DDD/100天(3%)、头孢曲松3.06 DDD/100天(1%)。90%的DU段抗生素为头孢克肟和氨苄西林。结论:头孢克肟141.63 DDD/100天是对支气管肺炎患者抗生素治疗最定量的描述评价。【关键词】抗生素;支气管肺炎;DDD【摘要】支气管肺炎;彭哥巴坦，甲氧基乙基乙基乙基乙基乙基乙基乙基乙基乙基乙基乙基乙基乙基。Di berbagai rumah sakit, ditemukan 30-80% penggunaan抗生素tidak didasarkan padinkasi yang tepat。Penelitian ini bertujuan untuk mengetahui gambaran评估terapi抗生素对帕潘西诺帕潘西诺帕潘西诺帕潘西诺帕潘西诺研究中心教授Dr. Dr. Kandou Manado, 2017.07 - 2018.06。詹尼特·彭尼特·林唐:对彭尼特·林唐的设计进行了回顾。世卫组织评价孟古那坎方法定量DDD。Hasil评价抗生素DDD/100-哈里达41份样品:头孢克西姆141、63 DDD/100-哈里(48%)、氨苄西林123、51 DDD/100-哈里(42%)、头孢他西姆10、52 DDD/100-哈里(4%)、庆大霉素8、88 DDD/100-哈里(3%)、克兰非尼考8、68 DDD/100-哈里(3%)、丹头孢特里克森3、06 DDD/100-哈里(1%)。抗菌素阳masuk dalam段DU 90% yitu头孢克辛和氨苄西林。[j] [j] [j] [j] [j] [j] [j] [j]。Kata kunci:抗生素，支气管肺炎，DDD
Gambaran Evaluasi Terapi Antibiotik pada Pasien Bronkopneumonia di Instalasi Rawat Inap Anak RSUP Prof. Dr. R. D. Kandou Manado Periode Juli 2017 – Juni 2018
Abstract: Bronchopneumonia is still one of the health problems worldwide due to its high mortality rate. The definitive treatment for this disease is antibiotics. However, the use of antibiotics in hospitals is 30-80% not for the right indication. This study was aimed to obtain the description of evaluation of antibiotic therapy in bronchopneumonia patients in the Pediatrics Inpatient Installation of Prof. Dr. R. D. Kandou Hospital Manado in the period of July 2017 - June 2018. This was a descriptive retrospective study with a cross-sectional design. Evaluation was done by using quantitative methods of DDD by WHO. The results of DDD/100-day evaluation using 41 samples were cefixime 141.63 DDD/100-day (48%), ampicillin 123.51 DDD /100-day (42%), cefotaxime 10.52 DDD/100-day (4%), gentamicin 8.88 DDD/ 100-day (3%), chloramphenicol 8.68 DDD/100-day (3%), and ceftriaxone 3.06 DDD/100-day (1%). Antibiotics included in 90% of the DU segment were cefixime and ampicillin. Conclusion: The most quantitative description evaluation of antibiotic therapy in bronchopneumonia patients was cefixime 141.63 DDD/100-day.Keywords: antibiotics, bronchopneumonia, DDD Abstrak: Bronkopneumonia menjadi salah satu masalah kesehatan di dunia karena angka kematiannya yang tinggi. Pengobatan definitifnya yaitu dengan pemberian antibiotik. Di berbagai rumah sakit, ditemukan 30-80% penggunaan antibiotik tidak didasarkan pada indikasi yang tepat. Penelitian ini bertujuan untuk mengetahui gambaran evaluasi terapi antibiotik pada pasien bronkopneumonia di Instalasi Rawat Inap Anak RSUP Prof. Dr. R. D. Kandou Manado periode Juli 2017 - Juni 2018. Jenis penelitian ialah deskriptif retrospektif dengan desain potong lintang. Evaluasi menggunakan metode kuantitatif DDD oleh WHO. Hasil evaluasi antibiotik DDD/100-hari dari 41 sampel yaitu cefiksim 141,63 DDD/100-hari (48%), ampicilin 123,51 DDD/100-hari (42%), cefotaksim 10,52 DDD/100-hari (4%), gentamisin 8,88 DDD/100-hari (3%), kloramfenikol 8,68 DDD/100-hari (3%), dan ceftriakson 3,06 DDD/100-hari (1%). Antibiotik yang masuk dalam segmen DU 90% yaitu cefiksim dan ampicilin. Simpulan: Secara kuantitas gambaran evaluasi terapi antibiotik terbanyak pada pasien bronkopneumonia yaitu cefiksim 141,63 DDD/100-hari.Kata kunci: antibiotik, bronkopneumonia, DDD
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
